Загрузка...
Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice
BACKGROUND: Metformin, an FDA-approved drug for the treatment of Type II diabetes, has emerged as a promising anti-cancer agent. Other biguanide analogs, including buformin and phenformin, are suggested to have similar properties. Although buformin was shown to reduce mammary tumor burden in carcino...
Сохранить в:
| Опубликовано в: : | J Exp Clin Cancer Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5307817/ https://ncbi.nlm.nih.gov/pubmed/28193239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0498-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|